At doses of 1 and 2 g / kg, Andiabet reduced insulin resistance by indirect assession through the improved glucose, sucrose and starch tolerance tests in normal and type 2 diabetic mice and direct evaluation by hyperinsulinemic-euglycemic clamp in conscious, unrestrained mice.